Approval · Notice of Compliance 35356 · 2025
NOVAMOXIN: Notice of Compliance 35356
Issued May 13, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 35356
- Date
- May 13, 2025
- Company
- Teva Canada LimitedToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to the Product Monograph with new safety information .
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NOVAMOXIN | Not yet assigned | — |
| NOVAMOXIN (SUGAR REDUCED) | Not yet assigned | — |
Medicinal ingredients
- AMOXICILLIN TRIHYDRATE 250 MG per CAP
- AMOXICILLIN TRIHYDRATE 500 MG per CAP
- AMOXICILLIN TRIHYDRATE 250 MG per TAB
- AMOXICILLIN TRIHYDRATE 250 MG per 5ML